Table 2.
Odds ratios (ORs) and 95% confidence intervals (CIs) for GCLM (-588C/T) and GCLC (-129T/C) genes in studied general mixed groups.
| Gene polymorphism | Genotype | Controls | IHD patients | OR (95% CI) | p value |
|---|---|---|---|---|---|
| GCLM (-588C/T) | CC | 250 | 229 | 0.64 (0.46–0.88) | 0.009 |
| CT | 87 | 119 | 1.44 (1.04–2.00) | ||
| TT | 4 | 12 | 2.91 (0.93–9.10) | ||
| GCLM (-588C/T) dominant model | CC + CT | 337 | 348 | 0.34 (0.11–1.08) | 0.05 |
| TT | 4 | 12 | 2.91 (0.93–9.10) | ||
| GCLM (-588C/T) receive model | CC | 250 | 229 | 0.64 (0.46–0.88) | 0.006 |
| CT + TT | 91 | 131 | 1.57 (1.14–2.17) | ||
| GCLC (-129T/C) | CC | 268 | 257 | 0.68 (0.48–0.96) | 0.03 |
| CT | 70 | 93 | 1.35 (0.95–1.92) | ||
| TT | 3 | 10 | 3.22 (0.88–11.80) | ||
| GCLC (-129T/C) dominant model | CC + CT | 338 | 350 | 0.31 (0.08–1.14) | 0.06 |
| TT | 3 | 10 | 3.22 (0.88–11.80) | ||
| GCLC (-129T/C) receive model | CC | 268 | 257 | 0.68 (048–0.96) | 0.03 |
| CT + TT | 73 | 103 | 1.47 (1.04–2.08) |